James L. Tyree, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 17,321 shares at $53.20 ($924K) on 2008-03-03, disclosed to the SEC on 2008-03-04.
Scheduled sale ($924k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.22 | 2,683 | $145K | 15.7% |
| 2 | $53.19 | 4,438 | $236K | 25.5% |
| 3 | $53.20 | 3,800 | $202K | 21.9% |
| 4 | $53.21 | 700 | $37K | 4.0% |
| 5 | $53.22 | 1,500 | $80K | 8.6% |
| 6 | $53.23 | 2,000 |
| $106K |
| 11.5% |
| 7 | $53.24 | 1,200 | $64K | 6.9% |
| 8 | $53.25 | 1,000 | $53K | 5.8% |
| Total | $53.37 avg | 17,321 | $924K | 100% |
| Filing → |
| ASRT | SELL | 2024-03-15 | $11K | — | Filing → |
| GNLX | SELL | 2023-12-14 | $192K | — | Filing → |
| ASRT | SELL | 2023-05-05 | $259K | — | Filing → |